ClinicalTrials.gg

Program

Pregabalin

Also written as “pregabalin”, “pregabalin (Lyrica)” and “Pregabalin ER”.

Its studies are mostly in Neuralgia · Fibromyalgia · Diabetic Neuropathies · Epilepsies, Partial · Neuralgia, Postherpetic, led by 18 companies.

Furthest: phase 4, since Aug 31, 2005142 company-led studies, 1 open or runningNext primary completion: Jun 1, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Viatris940 open or runningphase 4since Aug 31, 2005Aug 30, 2005none ahead
Pfizer180 open or runningphase 4since Apr 16, 2012Aug 30, 2005none ahead
Yuhan80 open or runningphase 4since Apr 13, 2021Aug 17, 2011none ahead
GL Pharm Tech40 open or runningphase 1since Jul 4, 2012Jul 4, 2012none ahead
Laboratorios Silanes S.A. de C.V.30 open or runningphase 3since Apr 4, 2022Apr 4, 2022none ahead
Merck20 open or runningphase 1since Dec 7, 2007Dec 7, 2007none ahead
Nevakar20 open or runningphase 2since Jul 27, 2020Jan 29, 2020none ahead
analgesic-solutions10 open or runningphase 4since Dec 13, 2012Dec 13, 2012none ahead
depomed10 open or runningphase 4since Jun 5, 2017Jun 5, 2017none ahead
Dexa Medica Group10 open or runningno phasesince Sep 4, 2014Sep 4, 2014none ahead
Egymedicalpedia10 open or runningearly phase 1since Apr 8, 2023Apr 8, 2023none ahead
Hypera Pharma11 open or runningphase 3since Jun 18, 2026Jun 18, 2026Jun 1, 2027phase 3 · NCT07712913
Jiangsu HengRui Medicine10 open or runningphase 3since Jul 8, 2015Jul 8, 2015none ahead
krka10 open or runningphase 4since Jan 24, 2020Jan 24, 2020none ahead
Latigo Biotherapeutics10 open or runningearly phase 1since Sep 13, 2024Sep 13, 2024none ahead
unimed-pharmaceuticals10 open or runningphase 1since Mar 3, 2013Mar 3, 2013none ahead
yung-shin-pharm-ind-co-ltd10 open or runningphase 4since Oct 8, 2018Oct 8, 2018none ahead
yungjin-pharm-co-ltd10 open or runningphase 1since Aug 22, 2017Aug 22, 2017none ahead

Also a collaborator on its studies: nevakar-injectables-inc, Boehringer Ingelheim and Astellas Pharma.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 46 studies since Nov 23, 2009.

  1. Oct 8, 2018yung-shin-pharm-ind-co-ltd's first study: phase 4 study in FibromyalgiaNew to yung-shin-pharm-ind-co-ltdyung-shin-pharm-ind-co-ltd · NCT03712475 · 28 enrolled · Taiwan
  2. Jan 24, 2020krka's first study: phase 4 study in Painful Diabetic Peripheral NeuropathyNew to krkakrka · NCT04246619 · 254 enrolled · Croatia, North Macedonia, Poland and more
  3. Jan 29, 2020Nevakar's first study: phase 1 study in Pain, PostoperativeNew to NevakarNevakar · NCT04265456 · 63 enrolled · United States
  4. Jul 27, 2020Phase 2 study in Pain, PostoperativeNevakar · NCT04495283 · 87 enrolled · United States
  5. Apr 13, 2021Phase 4 study in Diabetic Peripheral NeuropathyYuhan · NCT04846673 · 151 enrolled · Korea, Republic of
  6. Jul 27, 2021Phase 1 study in Healthy VolunteerYuhan · NCT05012436 · 16 enrolled · Korea, Republic of
  7. Sep 13, 2021Phase 4 study in Abuse PotentialViatris · NCT05053126 · 60 enrolled · United States
  8. Apr 4, 2022Laboratorios Silanes S.A. de C.V.'s first study: phase 3 study in NeuralgiaNew to Laboratorios Silanes S.A. de C.V.Laboratorios Silanes S.A. de C.V. · NCT05324059 · 110 enrolled · Mexico
  9. May 19, 2022Phase 1 study in Acute PainLaboratorios Silanes S.A. de C.V. · NCT05389150 · 30 enrolled · Mexico
  10. Nov 14, 2022Phase 4 study in NeuralgiaYuhan · NCT05624853 · 130 enrolled · Korea, Republic of
  11. Apr 8, 2023Egymedicalpedia's first study: early phase 1 study in Endoscopic Sinus SurgeryNew to EgymedicalpediaEgymedicalpedia · NCT05829148 · 120 enrolled · Egypt
  12. Jun 26, 2024Phase 3 study in Low Back PainLaboratorios Silanes S.A. de C.V. · NCT06516094 · 192 enrolled · Mexico
  13. Sep 13, 2024Latigo Biotherapeutics's first study: early phase 1 study in Pain DetectionNew to Latigo BiotherapeuticsLatigo Biotherapeutics · NCT06600607 · 20 enrolled · New Zealand
  14. Jun 18, 2026Hypera Pharma's first study: phase 3 study in Diabetic NeuropathiesNew to Hypera PharmaHypera Pharma · NCT07712913 · 348 planned · Brazil

Ahead

  1. Jun 1, 2027Primary completion: phase 3 study in Diabetic NeuropathiesHypera Pharma · NCT07712913

TargetBeta

“Voltage-gated calcium channel modulator”ChEMBL 37, by rule

Other programs on the same 26 targets

ProgramCompanyFurthest phaseStudies
GabapentinruleViatrisphase 449

Studies

The newest 60 of 142 led by companies developing it. Each opens its study page. Every study on its drug page →

StudyPhaseStatusLed byPrimary completionSize
NCT07712913Diabetic Neuropathies · Brazil3RecruitingHypera PharmaJun 1, 2027348
NCT06600607Pain Detection · New ZealandEarly 1CompletedLatigo BiotherapeuticsOct 27, 202420
NCT06516094Low Back Pain · Mexico3CompletedLaboratorios Silanes S.A. de C.V.Jan 1, 2025192
NCT05829148Endoscopic Sinus Surgery · EgyptEarly 1UNKNOWNEgymedicalpediaNov 1, 2024120
NCT05624853Neuralgia · Korea, Republic of4CompletedYuhanDec 20, 2022130
NCT05389150Acute Pain · Mexico1CompletedLaboratorios Silanes S.A. de C.V.Feb 5, 201930
NCT05324059Neuralgia · Mexico3CompletedLaboratorios Silanes S.A. de C.V.Apr 18, 2023110
NCT05053126Abuse Potential · United States4CompletedViatrisApr 1, 202260
NCT05012436Healthy Volunteer · Korea, Republic of1CompletedYuhanMay 10, 202216
NCT04846673Diabetic Peripheral Neuropathy · Korea, Republic of4CompletedYuhanNov 30, 2022151
NCT04495283Pain, Postoperative · United States2CompletedNevakarNov 12, 202087
NCT04265456Pain, Postoperative · United States1CompletedNevakarJun 15, 202063
NCT04246619Painful Diabetic Peripheral Neuropathy · Croatia, North Macedonia, Poland and more4TerminatedkrkaDec 21, 2021254
NCT03712475Fibromyalgia · Taiwan4Completedyung-shin-pharm-ind-co-ltdSep 16, 201828
NCT03261427Healthy · Korea, Republic of1Completedyungjin-pharm-co-ltdOct 11, 201717
NCT03179345Healthy4CompleteddepomedNov 20, 201532
NCT03191136Peripheral Neuropathic Pain · Korea, Republic of1CompletedYuhanJun 27, 201724
NCT02985216Peripheral Neuropathic Pain · Korea, Republic of3CompletedYuhanApr 27, 2018371
NCT02783183Peripheral Nueropathy Pain1CompletedYuhanAug 201632
NCT02783638Peripheral Neuropathy Pain · Korea, Republic of1CompletedYuhanApr 201664
NCT02725112Healthy · United States1CompletedViatrisMay 22, 201625
NCT02868801Neuralgia, Postherpetic · China3UNKNOWNJiangsu HengRui MedicineJun 2017280
NCT02327000Healthy1CompletedGL Pharm TechOct 201440
NCT02326987Healthy1CompletedGL Pharm TechNov 201330
NCT02233777Healthy · Indonesia–CompletedDexa Medica GroupJun 201420
NCT02215252Diabetic Neuropathies · United States2CompletedPfizerJul 15, 2015141
NCT02072824Epilepsy · United States, Belarus, Belgium and more3CompletedViatrisMar 13, 2018175
NCT01838044Chronic Low Back Pain With a Neuropathic Component · Brazil, Chile, Colombia and more4TerminatedViatrisMay 2015180
NCT01808300Healthy1Completedunimed-pharmaceuticalsJul 201342
NCT01770964Diabetes Mellitus · United States4UNKNOWNanalgesic-solutionsJul 201390
NCT01747915Seizures · United States, Austria, Belarus and more3CompletedViatrisFeb 20, 2019219
NCT01727791Breast Feeding · Belgium4CompletedViatrisAug 201310
NCT01701362Neuralgia · United States, Bulgaria, Canada and more3CompletedViatrisAug 2015542
NCT01638273Healthy · Korea, Republic of1CompletedGL Pharm TechJul 201424
NCT01635751Healthy · Korea, Republic of1CompletedGL Pharm TechNov 201230
NCT01603394Neuralgia, Postherpetic · United States, Austria, Germany and more4TerminatedPfizerJun 20139
NCT01474772Diabetic Peripheral Neuropathy · United States, Czechia, South Africa and more3CompletedViatrisJul 2013217
NCT01463306Epilepsy · United States, Belarus, Belgium and more3CompletedViatrisAug 22, 2019605
NCT01455428Neuralgia, Postherpetic · China4CompletedViatrisJan 2014223
NCT01455415Painful Diabetic Peripheral Neuropathy · United States, Czechia, Italy and more3CompletedViatrisNov 2013306
NCT01432236Fibromyalgia · United States, Canada, Italy and more3CompletedViatrisJul 2013197
NCT01420913Healthy · Korea, Republic of1CompletedYuhanAug 201128
NCT01387607Fibromyalgia · China3CompletedViatrisOct 31, 2016343
NCT01332149Diabetic Neuropathies · China3CompletedViatrisApr 2014626
NCT01298466Low Back Pain4WithdrawnViatrisFeb 20130
NCT01271933Fibromyalgia · United States, Canada, India and more3CompletedViatrisJul 2012441
NCT01270828Neuralgia, Postherpetic · United States, Bulgaria, Colombia and more3CompletedViatrisSep 2014806
NCT01262677Seizures · United States, Argentina, Bosnia and Herzegovina and more3CompletedViatrisJul 31, 2012325
NCT01257516Healthy · Belgium1CompletedViatrisMar 201118
NCT01220219Healthy · Belgium1CompletedViatrisJan 201124
NCT01202435Healthy · Belgium1CompletedViatrisNov 201018
NCT01202422Healthy · Belgium1CompletedViatrisNov 201024
NCT01202227Spinal Cord Diseases · Japan3CompletedViatrisMar 2012104
NCT01145417Neuralgia · United States, Colombia, India and more3TerminatedViatrisMay 2012217
NCT01117766Neuralgia · Austria, Belgium, France and more–CompletedPfizerSep 200931
NCT01080612Healthy · United States1CompletedViatrisJun 201024
NCT01061372Restless Legs Syndrome3WithdrawnViatrisAug 20110
NCT01057693Diabetic Neuropathies · United States, Canada, Puerto Rico and more3CompletedViatrisJan 30, 2012633
NCT01049217Pain · United States, Colombia, Dominican Republic and more3TerminatedViatrisMay 2012377
NCT01020526Fibromyalgia · United States, Czechia, India4CompletedViatrisJun 201563

How it is read

Names in the registry

  • “Pregabalin”, 80 entries
  • “pregabalin”, 43 entries
  • “pregabalin (Lyrica)”, 7 entries
  • “Pregabalin ER”, 6 entries
  • “Pregabalin 150mg”, 5 entries

Codes read as this program: YHD1119.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.